Actinium Pharmaceuticals, Inc. (ATNM)
EBITDA Margin
80.41%
Quarterly · Period ending:
ATNM EBITDA Margin
Latest reported80.41%period ending
Latest reported80.41%period ending
ATNM Quarterly EBITDA Margin (0.00% → 80.41%)
Quarterly ebitda margin
High-resolution chart · PNG
ATNM ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 80.4057% | |
| 0% | |
| 0% | |
| -5,472.2222% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -11,265.4321% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -20,562.2222% | |
| -16,860% | |
| -531.0638% | |
| -34,230.4348% | |
| -2,699.5708% | |
| -1,839.0977% | |
| -843.5691% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 186,565.097% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |